Wang et al., 2010 - Google Patents
922 Angiotensin Converting Enzyme Modulates Epithelial Cell Apoptosis in a Massive Intestinal Resection Rat Model: Role of At1r ReceptorWang et al., 2010
- Document ID
- 5849268353503200406
- Author
- Wang W
- Yang H
- Xiao W
- Sun L
- Zhang C
- Cai Y
- Chen W
- Teitelbaum D
- Publication year
- Publication venue
- Gastroenterology
External Links
- 230000000968 intestinal effect 0 title abstract description 20
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11590176B2 (en) | Compositions of microbiota and methods related thereto | |
| Martín et al. | Faecalibacterium: a bacterial genus with promising human health applications | |
| Li et al. | Probiotic mixture of Lactobacillus plantarum strains improves lipid metabolism and gut microbiota structure in high fat diet-fed mice | |
| Wang et al. | Gut microbiota mediates the anti-obesity effect of calorie restriction in mice | |
| Mazidi et al. | Gut microbiome and metabolic syndrome | |
| Villanueva-Millán et al. | Gut microbiota: a key player in health and disease. A review focused on obesity | |
| TWI572354B (en) | Anti-inflammatory composition | |
| Tang et al. | The therapeutic value of bifidobacteria in cardiovascular disease | |
| JP2018532779A (en) | Felicaribacterium prausnitzi and desulfobibriopigel for use in the treatment or prevention of diabetes and bowel disease | |
| Dai et al. | Anti-inflammatory effects of newly synthesized α-galacto-oligosaccharides on dextran sulfate sodium-induced colitis in C57BL/6J mice | |
| CN113755409B (en) | Bifidobacterium longum for relieving insulin resistance and application thereof | |
| Yang et al. | Alleviating effect of Lactobacillus rhamnosus SDSP202418 on exercise-induced fatigue in mice | |
| Wang et al. | 922 Angiotensin Converting Enzyme Modulates Epithelial Cell Apoptosis in a Massive Intestinal Resection Rat Model: Role of At1r Receptor | |
| Barnes et al. | 923 The Addition of Synbiotics to Partial Enteral Nutrition Enhances Intestinal Adaptation in a Piglet Model of Intestinal Failure | |
| Ramadass et al. | 924 Glutamine Attenuates the Toxic Effects of Legumes via Stimulation of HSP Production | |
| Huang et al. | Orlistat ameliorates lipid dysmetabolism in high-fat diet-induced mice via gut microbiota modulation | |
| US11641868B2 (en) | Synbiotic composition for preventing metabolic disorders | |
| CA3045073C (en) | Nutritional composition useful in the treatment of neoplastic diseases | |
| Poeker | Towards understanding the modulation potential of dietary fibers on intestinal microbiota using human and a novel murine intestinal fermentation model | |
| 서은솔 | Isolation and validation of Lactobacillus plantarum for probiotic characteristics and alpha-hydroxyisocaproic acid (HICA) production | |
| Kerem et al. | 10th Congress of the International Society of Nutrigenetics/Nutrigenomics (ISNN) | |
| Chen et al. | Probiotics reduced weight gain in mice for many weeks (proof of concept)–June 2014 |